Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis.
Saved in:
| Title: | Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis. |
|---|---|
| Authors: | Baldin VP; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA., Harding CL; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA., Quach D; Linnaeus Bioscience, Inc, San Diego, California, USA., Sugie J; Linnaeus Bioscience, Inc, San Diego, California, USA., Pogliano J; Linnaeus Bioscience, Inc, San Diego, California, USA., Parish T; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Nov 05; Vol. 69 (11), pp. e0098025. Date of Electronic Publication: 2025 Sep 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
